A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
NCT05335369 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 161
Last updated 2026-05-11
Summary
The objective of this study is to evaluate the preliminary efficacy of the UR-GOAL tool in improving shared decision making and communication between older patients with AML and their oncologists in a pilot randomized trial.
Conditions
Interventions
- BEHAVIORAL
-
UR-GOAL
UR-GOAL helps conducts assessments of fitness, elicits patient values via Best-Worst Scaling, and elicits preferences for prognostic information and assesses prognostic awareness. The tool also includes an AML educational video.
Sponsors & Collaborators
-
University of Rochester
lead OTHER
Principal Investigators
-
Kah Poh Loh · University of Rochester
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-17
- Primary Completion
- 2025-04-07
- Completion
- 2025-10-06
Countries
- United States
Study Locations
More Related Trials
-
Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a
NCT01497002 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience.
NCT03350152 ·Status: COMPLETED
-
Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AML
NCT03023384 ·Status: UNKNOWN
-
Psychological Intervention Mobile App for Patients With AML
NCT03372291 ·Status: COMPLETED ·Phase: NA
-
Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories
NCT07263074 ·Status: RECRUITING ·Phase: NA
-
Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study
NCT06323590 ·Status: ACTIVE_NOT_RECRUITING
-
Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia
NCT06990321 ·Status: RECRUITING ·Phase: PHASE3
-
Novel Digital Application for Patients With Acute Leukemia
NCT06472128 ·Status: RECRUITING ·Phase: NA
-
Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy
NCT03603795 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
NCT00091234 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Quality of Life Model for Older Patients With AML
NCT04380441 ·Status: ACTIVE_NOT_RECRUITING
-
High-dose Cytarabine and Survival in AML
NCT01034839 ·Status: COMPLETED
-
Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia
NCT04885127 ·Status: COMPLETED ·Phase: NA
-
Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia
NCT01039363 ·Status: UNKNOWN ·Phase: PHASE2
-
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
NCT02038153 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study on Optimizing the Treatment of Patients With Acute Myeloid Leukemia Based on Early Peripheral Blood Minimal Residual Disease
NCT07023588 ·Status: RECRUITING ·Phase: PHASE2
-
Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALL
NCT03460522 ·Status: RECRUITING ·Phase: PHASE2
-
Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia
NCT00037596 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients
NCT00631059 ·Status: TERMINATED ·Phase: NA
-
FLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AML
NCT00559221 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival
NCT03549351 ·Status: TERMINATED
-
Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75
NCT03902665 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.
NCT00363025 ·Status: TERMINATED ·Phase: PHASE3
-
Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)
NCT04777916 ·Status: RECRUITING
-
Investigating the Relationship Between Physical Function, Comorbidity and Cytogenetic Risk Group in Older Adults With Acute Myelogenous Leukemia (AML)
NCT02662933 ·Status: COMPLETED ·Phase: NA